Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marieke J.H. Begemann"'
Autor:
Marieke J.H. Begemann, Mascha M.J. Linszen, Janna N. de Boer, Wytske D. Hovenga, Shiral S. Gangadin, Maya J.L. Schutte, Iris E.C. Sommer
Publikováno v:
Frontiers in Psychiatry, Vol 10 (2019)
Introduction: Building upon the comorbidity between atopy and schizophrenia, we conducted a large cross-sectional, observational population-based study to examine if such associations also exist between atopic disorders (eczema, allergic rhinitis, an
Externí odkaz:
https://doaj.org/article/efcbedd60d1c4f1e9421597fa6bcb54c
Autor:
Marc Bohlken, Isolde L. Maas, Shiral Gangadin, Bram-Sieben Rosema, W. Veling, Nynke Boonstra, Lieuwe de Haan, Marieke J.H. Begemann, Sanne Koops
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d872d2ca14731b8201764e525eae7d99
https://doi.org/10.2139/ssrn.4423570
https://doi.org/10.2139/ssrn.4423570
Autor:
Jasper O. Nuninga, Steven C. Bakker, Metten Somers, Marco P. Boks, Marieke J.H. Begemann, Sophie M. Heringa, Wendy Nieuwdorp, René C.W. Mandl, Thomas F.I. Claessens, Iris E. C. Sommer
Publikováno v:
Journal of Affective Disorders, 238, 659-665. ELSEVIER SCIENCE BV
Journal of Affective Disorders, 238, 659. Elsevier
Journal of Affective Disorders, 238, 659. Elsevier
Background: Electroconvulsive therapy (ECT) is the most effective treatment for patients suffering from major depression. However, its use is limited due to concerns about negative effects on cognition. Unilateral ECT is associated with transient cog
Efficacy of different types of cognitive enhancers for patients with schizophrenia : a meta-analysis
Autor:
Iris E. C. Sommer, Jolien D. Jacobs, Bob Oranje, Merel Prikken, Rune A. Kroken, Marieke J.H. Begemann, Wan U. Lei, Kenneth Hugdahl, Carina Rau, Silvia Mattaroccia, Erik Johnsen, Igne Sinkeviciute
Publikováno v:
npj Schizophrenia, Vol 4, Iss 1, Pp 1-14 (2018)
NPJ Schizophrenia
npj Schizophrenia, 4(1). Nature Publishing Group
Nature NPJ Schizophrenia
npj Schizophrenia
NPJ Schizophrenia, 4:22. SPRINGERNATURE
NPJ Schizophrenia
npj Schizophrenia, 4(1). Nature Publishing Group
Nature NPJ Schizophrenia
npj Schizophrenia
NPJ Schizophrenia, 4:22. SPRINGERNATURE
Cognitive impairment is a core feature of schizophrenia, which is predictive for functional outcomes and is, therefore, a treatment target in itself. Yet, literature on efficacy of different pharmaco-therapeutic options is inconsistent. This quantita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce9058e802d14ea1c5d762d596ba342
https://dspace.library.uu.nl/handle/1874/373934
https://dspace.library.uu.nl/handle/1874/373934
Autor:
Neeltje E.M. van Haren, Lucija Abramovic, Marieke J.H. Begemann, Christiaan H. Vinkers, Sanne Verkooijen, Iris E. C. Sommer, Remi Stevelink, René C.W. Mandl, Marco P. Boks
Publikováno v:
European Neuropsychopharmacology, 28(7), 807-817. ELSEVIER SCIENCE BV
European Neuropsychopharmacology, 28(7), 807-817. Elsevier
European Neuropsychopharmacology, 28(7), 807-817. Elsevier
Childhood trauma has a negative impact on the developing brain and increases the risk for almost all psychiatric disorders including bipolar disorder. White matter abnormalities may play a role in the persistently increased risk for bipolar disorder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edfdb226e04863578c60858eb210b85d
https://research.rug.nl/en/publications/19e060e0-9c95-4c72-a9f6-f6e76591c2f7
https://research.rug.nl/en/publications/19e060e0-9c95-4c72-a9f6-f6e76591c2f7
Publikováno v:
NPJ Schizophrenia
npj Schizophrenia, Vol 4, Iss 1, Pp 1-6 (2018)
npj Schizophrenia, Vol 4, Iss 1, Pp 1-6 (2018)
Recognizing the robust sex differences in schizophrenia prevalence, the selective estrogen receptor modulator (SERM) raloxifene is a likely candidate for augmentation therapy in this disorder. Therefore, a systematic search was performed using PubMed
Publikováno v:
Schizophrenia Bulletin, 42(3), 588
Schizophrenia Bulletin, 42(3), 588-599. Oxford University Press
Schizophrenia Bulletin, 42(3), 588. Oxford University Press
Dauwan, M, Begemann, M J H, Heringa, S M & Sommer, I E 2016, ' Exercise improves clinical symptoms, quality of life, global functioning, and depression in schizophrenia : A systematic review and meta-analysis ', Schizophrenia Bulletin, vol. 42, no. 3, pp. 588-599 . https://doi.org/10.1093/schbul/sbv164
Schizophrenia Bulletin, 42(3), 588-599. Oxford University Press
Schizophrenia Bulletin, 42(3), 588. Oxford University Press
Dauwan, M, Begemann, M J H, Heringa, S M & Sommer, I E 2016, ' Exercise improves clinical symptoms, quality of life, global functioning, and depression in schizophrenia : A systematic review and meta-analysis ', Schizophrenia Bulletin, vol. 42, no. 3, pp. 588-599 . https://doi.org/10.1093/schbul/sbv164
Background: Physical exercise may be valuable for patients with schizophrenia spectrum disorders as it may have beneficial effect on clinical symptoms, quality of life and cognition. Methods: A systematic search was performed using PubMed (Medline),
Autor:
Neeltje E.M. van Haren, Iris E. C. Sommer, Marieke J.H. Begemann, Maya J. L. Schutte, Margot I. E. Slot, P. Roberto Bakker, Janine Doorduin
Publikováno v:
BBA Clinical, 4, 52. Elsevier B.V.
Biochimica et Biophysica Acta. Clinical, 4, 52-58. Elsevier
Clinical Journal of the American Society of Nephrology, 4, 52-58. AMER SOC NEPHROLOGY
BBA Clinical
Biochimica et Biophysica Acta. Clinical, 4, 52-58. Elsevier
Clinical Journal of the American Society of Nephrology, 4, 52-58. AMER SOC NEPHROLOGY
BBA Clinical
There is ample evidence that inflammatory processes play a role in the pathophysiology of schizophrenia. Randomized controlled trials have shown benefit of some (but not all) anti-inflammatory drugs on symptom severity. So far, these drugs have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc75039ae7a967f33427941ca8135488
https://dspace.library.uu.nl/handle/1874/331704
https://dspace.library.uu.nl/handle/1874/331704